Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

February 1, 2015; Volume 56,Issue 2

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 8A;

SNMMI Newsline

  • You have access
    Commentary: Quality: Commandment and Conundrum
    Alexandru Bageac
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 9N;
  • You have access
    ABNM International In-Training Examination Program
    J. Anthony Parker
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 10N;
  • You have access
    In Memoriam: David L. Yuille, MD, 1942–2014
    Shobha Desai
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 11N;
  • You have access
    SNMMI Leadership Update: Clinical Trials Network: From Clinical Trials to Practice
    Virginia Pappas
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 12N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 13N-15N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 16N-20N;

Focus on Molecular Imaging

  • You have access
    Combined PET/MR: A Technology Becomes Mature
    Hans F. Wehrl, Alexander W. Sauter, Mathew R. Divine and Bernd J. Pichler
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 165-168; DOI: https://doi.org/10.2967/jnumed.114.150318

Invited Perspectives

  • You have access
    Molecular Imaging of Prostate Cancer: Tapping into the Opportunities
    Wim J.G. Oyen and Igle J. De Jong
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 169-170; DOI: https://doi.org/10.2967/jnumed.114.150219

Clinical Investigations

  • You have access
    Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
    Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont, Philippe Brunner, Jan Müller-Brand, Helmut R. Maecke, Matthias Briel and Martin A. Walter
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 171-176; DOI: https://doi.org/10.2967/jnumed.114.147256
  • You have access
    Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE
    Ezgi Ilan, Mattias Sandström, Cecilia Wassberg, Anders Sundin, Ulrike Garske–Román, Barbro Eriksson, Dan Granberg and Mark Lubberink
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.114.148437
  • You have access
    Risk Stratification of Metastatic Neck Nodes by CT and PET in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy
    Ying-Chun Lin, Shang-Wen Chen, Te-Chun Hsieh, Kuo-Yang Yen, Shih-Neng Yang, Yao-Ching Wang and Chia-Hung Kao
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 183-189; DOI: https://doi.org/10.2967/jnumed.114.148023
  • You have access
    Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
    Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis Görlich, Christian Wenning, Michael Schaefers, Burkhard Riemann and Alexis Vrachimis
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 190-195; DOI: https://doi.org/10.2967/jnumed.114.150284
  • You have access
    Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non–Small Cell Lung Cancer
    Jérémie Calais, Sébastien Thureau, Bernard Dubray, Romain Modzelewski, Luc Thiberville, Isabelle Gardin and Pierre Vera
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 196-203; DOI: https://doi.org/10.2967/jnumed.114.144253
  • You have access
    18F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
    Charles Marcus, Vasavi Paidpally, Alexander Antoniou, Atif Zaheer, Richard L. Wahl and Rathan M. Subramaniam
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 204-208; DOI: https://doi.org/10.2967/jnumed.114.147884
  • You have access
    Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients
    Marino Cimitan, Laura Evangelista, Marina Hodolič, Giuliano Mariani, Tanja Baseric, Valentina Bodanza, Giorgio Saladini, Duccio Volterrani, Anna Rita Cervino, Michele Gregianin, Giulia Puccini, Federica Guidoccio, Jure Fettich and Eugenio Borsatti
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 209-215; DOI: https://doi.org/10.2967/jnumed.114.141887
  • You have access
    18F-FDG or 3′-Deoxy-3′-18F-Fluorothymidine to Detect Transformation of Follicular Lymphoma
    Marielle J. Wondergem, Saiyada N.F. Rizvi, Yvonne Jauw, Otto S. Hoekstra, Nikie Hoetjes, Peter M. van de Ven, Ronald Boellaard, Martine E.D. Chamuleau, Saskia A.G.M. Cillessen, Josien C. Regelink, Sonja Zweegman and Josée M. Zijlstra
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 216-221; DOI: https://doi.org/10.2967/jnumed.114.149625
  • You have access
    18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
    Bruce E. Hillner, Barry A. Siegel, Lucy Hanna, Fenghai Duan, Bruce Quinn and Anthony F. Shields
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 222-228; DOI: https://doi.org/10.2967/jnumed.114.150391
  • You have access
    Relationship Between Alzheimer Disease–Like Pattern of 18F-FDG and Fasting Plasma Glucose Levels in Cognitively Normal Volunteers
    Kenji Ishibashi, Airin Onishi, Yoshinori Fujiwara, Kiichi Ishiwata and Kenji Ishii
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 229-233; DOI: https://doi.org/10.2967/jnumed.114.150045
  • You have access
    Use of 11C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders
    Lieuwe Appel, My Jonasson, Torsten Danfors, Dag Nyholm, Håkan Askmark, Mark Lubberink and Jens Sörensen
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 234-242; DOI: https://doi.org/10.2967/jnumed.114.148619
  • You have access
    Test–Retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor
    Mika Naganawa, Ming-Qiang Zheng, Shannan Henry, Nabeel Nabulsi, Shu-Fei Lin, Jim Ropchan, David Labaree, Soheila Najafzadeh, Michael Kapinos, Johannes Tauscher, Alexander Neumeister, Richard E. Carson and Yiyun Huang
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 243-248; DOI: https://doi.org/10.2967/jnumed.114.147975
  • You have access
    PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
    Nikolaos E. Makris, Ronald Boellaard, Arthur van Lingen, Adriaan A. Lammertsma, Guus A.M.S. van Dongen, Henk M. Verheul, Catharina W. Menke and Marc C. Huisman
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 249-254; DOI: https://doi.org/10.2967/jnumed.114.147819
  • You have access
    Integrated 18F-FDG PET/MR Imaging in the Assessment of Cardiac Masses: A Pilot Study
    Felix Nensa, Ercan Tezgah, Thorsten D. Poeppel, Christoph J. Jensen, Juliane Schelhorn, Jens Köhler, Philipp Heusch, Oliver Bruder, Thomas Schlosser and Kai Nassenstein
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 255-260; DOI: https://doi.org/10.2967/jnumed.114.147744
  • You have access
    Motion Correction Strategies for Integrated PET/MR
    Sebastian Fürst, Robert Grimm, Inki Hong, Michael Souvatzoglou, Michael E. Casey, Markus Schwaiger, Stephan G. Nekolla and Sibylle I. Ziegler
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 261-269; DOI: https://doi.org/10.2967/jnumed.114.146787

Brief Communications

  • You have access
    Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease
    Yi Li, Wai Tsui, Henry Rusinek, Tracy Butler, Lisa Mosconi, Elizabeth Pirraglia, David Mozley, Shankar Vallabhajosula, Ryuichi Harada, Shozo Furumoto, Katsutoshi Furukawa, Hiroyuki Arai, Yukitsuka Kudo, Nobuyuki Okamura and Mony J. de Leon
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 270-273; DOI: https://doi.org/10.2967/jnumed.114.149229

Continuing Education

  • You have access
    Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies
    Lebriz Uslu, Jessica Donig, Michael Link, Jarrett Rosenberg, Andrew Quon and Heike E. Daldrup-Link
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 274-286; DOI: https://doi.org/10.2967/jnumed.114.146290

Basic Science Investigations

  • You have access
    111In-Cetuximab-F(ab′)2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
    Laura K. van Dijk, Otto C. Boerman, Gerben M. Franssen, Johannes H.A.M. Kaanders and Johan Bussink
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 287-292; DOI: https://doi.org/10.2967/jnumed.114.148296
  • You have access
    PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
    Clemens Kratochwil, Frederik L. Giesel, Karin Leotta, Matthias Eder, Torsten Hoppe-Tich, Hagop Youssoufian, Klaus Kopka, John W. Babich and Uwe Haberkorn
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 293-298; DOI: https://doi.org/10.2967/jnumed.114.147181
  • You have access
    Can the Inflammatory Response Be Evaluated Using 18F-FDG Within Zones of Microvascular Obstruction After Myocardial Infarction?
    Frank S. Prato, John Butler, Jane Sykes, Lynn Keenliside, Kimberley J. Blackwood, R. Terry Thompson, James A. White, Yoko Mikami, Jonathan D. Thiessen and Gerald Wisenberg
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 299-304; DOI: https://doi.org/10.2967/jnumed.114.147835
  • You have access
    In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis
    Laura Airas, Alex M. Dickens, Petri Elo, Päivi Marjamäki, Jarkko Johansson, Olli Eskola, Paul A. Jones, William Trigg, Olof Solin, Merja Haaparanta-Solin, Daniel C. Anthony and Juha Rinne
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 305-310; DOI: https://doi.org/10.2967/jnumed.114.149955
  • You have access
    PET Imaging of Translocator Protein (18 kDa) in a Mouse Model of Alzheimer's Disease Using N-(2,5-Dimethoxybenzyl)-2-18F-Fluoro-N-(2-Phenoxyphenyl)Acetamide
    Michelle L. James, Nadia P. Belichenko, Thuy-Vi V. Nguyen, Lauren E. Andrews, Zhaoqing Ding, Hongguang Liu, Deepika Bodapati, Natasha Arksey, Bin Shen, Zhen Cheng, Tony Wyss-Coray, Sanjiv S. Gambhir, Frank M. Longo and Frederick T. Chin
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 311-316; DOI: https://doi.org/10.2967/jnumed.114.141648
  • You have access
    123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1 In Vivo
    Geor Bakker, Wilhelmina A. Vingerhoets, Jan–Peter van Wieringen, Kora de Bruin, Jos Eersels, Jan de Jong, Youssef Chahid, Bart P. Rutten, Susan DuBois, Megan Watson, Adrian J. Mogg, Hongling Xiao, Michael Crabtree, David A. Collier, Christian C. Felder, Vanessa N. Barth, Lisa M. Broad, Oswald J. Bloemen, Thérèse A. van Amelsvoort and Jan Booij
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 317-322; DOI: https://doi.org/10.2967/jnumed.114.147488
  • You have access
    Optoacoustic Imaging of Naphthalocyanine: Potential for Contrast Enhancement and Therapy Monitoring
    Nicolas Bézière and Vasilis Ntziachristos
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 323-328; DOI: https://doi.org/10.2967/jnumed.114.147157

Book Reviews

  • You have access
    Molecular Imaging: Fundamentals and Applications
    Mei Tian
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 329; DOI: https://doi.org/10.2967/jnumed.114.153353

Erratum

  • You have access
    Erratum
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 329;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 56 (2)
Journal of Nuclear Medicine
Vol. 56, Issue 2
February 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Combined PET/MR: A Technology Becomes Mature
  • Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
  • 18F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
  • Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Focus on Molecular Imaging
  • Invited Perspectives
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Book Reviews
  • Erratum
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
  • Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire